PNAA
EXAS

Pictet North America Advisors’s Exact Sciences EXAS Stock Holding History

Pictet North America Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-102,700
Closed -$3.34M – 139
2022
Q3 		$3.34M Sell
102,700
-3,140
-3% -$129K 0.53% 39
2022
Q2 		$4.17M Sell
105,840
-3,338
-3% -$178K 0.55% 37
2022
Q1 		$7.63M Sell
109,178
-16,579
-13% -$1.21M 0.89% 31
2021
Q4 		$9.79M Buy
125,757
+445
+0.4% +$39.3K 0.96% 27
2021
Q3 		$12M Buy
125,312
+9,746
+8% +$1.03M 1.18% 27
2021
Q2 		$14.4M Buy
115,566
+28,691
+33% +$3.42M 1.48% 24
2021
Q1 		$11.4M Sell
86,875
-950
-1% -$130K 1.34% 24
2020
Q4 		$11.6M Buy
87,825
+5,552
+7% +$671K 1.47% 23
2020
Q3 		$8.39M Sell
82,273
-715
-0.9% -$61.7K 1.18% 24
2020
Q2 		$7.21M Buy
82,988
+5,729
+7% +$458K 1.03% 27
2020
Q1 		$4.48M Buy
+77,259
New +$6.27M 0.77% 31

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Pictet North America Advisors's EXAS Position: Q4 2022 in Review

Pictet North America Advisors sold out of Exact Sciences (EXAS) in Q4 2022, closing a stake of 102,700 shares — an estimated $3.34M sold.

Pictet North America Advisors first reported a position in EXAS in Q1 2020 and held it in 11 quarters. The position peaked at $14.4M in Q2 2021. 551 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.

  • Pictet North America Advisors reported no remaining Exact Sciences position as of Q4 2022 after selling out during the quarter.
  • Pictet North America Advisors sold 102,700 Exact Sciences shares in Q4 2022, an estimated $3.34M.
  • Pictet North America Advisors first reported a position in Exact Sciences in Q1 2020 and held it in 11 quarters.
  • Pictet North America Advisors's Exact Sciences position peaked at $14.4M in Q2 2021.
  • 551 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.

Based on Pictet North America Advisors's 13F filing for Q4 2022, filed 22 Mar 2023.